Welcome to our dedicated page for Inotiv SEC filings (Ticker: NOTV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Inotiv, Inc. filings document the regulatory record of an operating contract research organization with Discovery and Safety Assessment and Research Models and Services operations. Current reports furnish financial results and business updates, including segment-related discussion for nonclinical and analytical drug development services, research models, and related products.
Material-event filings also describe credit-agreement administration, including waivers tied to minimum liquidity covenants, Nasdaq listing-compliance notices, shareholder voting matters, and governance disclosures. The filings provide formal records of capital-structure obligations, operating results, risk-related events, and public-company compliance matters for NOTV common stock.
Inotiv, Inc. Chief Financial Officer Beth A. Taylor reported a routine tax-related share disposition. On the vesting of restricted stock units, 5,864 shares of common stock were withheld by Inotiv to cover tax withholding obligations. After this non-market transaction, Taylor directly holds 139,616 shares of Inotiv common stock.
Inotiv, Inc. director and Chief Strategy Officer John E. Sagartz reported a routine tax-withholding share disposition tied to equity compensation. On the vesting of restricted stock units, 6,071 shares of common stock were withheld by Inotiv, Inc. to satisfy tax withholding obligations, at a reported value of $0.0185 per share. After this non-market transaction, Sagartz directly holds 729,626 shares of Inotiv common stock.
Inotiv, Inc. insider Adrian Hardy reported a tax-related share disposition involving 5,371 shares of common stock. The shares were withheld by Inotiv to cover tax withholding obligations that arose when restricted stock units vested, rather than sold on the open market.
Following this withholding transaction, Hardy directly holds 53,049 shares of Inotiv common stock. This type of Form 4 event is a routine administrative step tied to equity compensation and does not reflect an active decision to buy or sell shares in the market.
Inotiv, Inc. executive Jeffrey Brennan reported a routine tax-related share disposition. On the vesting of restricted stock units, 5,855 shares of common stock were withheld by Inotiv to cover tax withholding obligations at an effective price of $0.0185 per share. After this withholding, Brennan directly holds 36,623 shares of Inotiv common stock. This was not an open-market purchase or sale, but an automatic mechanism tied to equity compensation vesting.
Inotiv, Inc. executive Andrea Castetter, EVP, General Counsel, Secretary and Chief Compliance Officer, reported a tax-related share disposition. On the vesting of restricted stock units, 5,800 shares of Common Stock were withheld by Inotiv to satisfy tax withholding obligations. After this non-market transaction, Castetter directly holds 49,200 shares of Inotiv Common Stock.
Inotiv, Inc. Chief Operating Officer John Gregory Beattie reported a routine tax-related share disposition. On the vesting of restricted stock units, 5,769 shares of common stock were withheld by Inotiv to satisfy tax withholding obligations, at a price of $0.0185 per share. After this withholding, Beattie directly holds 180,992 shares of Inotiv common stock. This was not an open-market sale but an automatic mechanism tied to equity compensation.
Inotiv, Inc. has entered Chapter 11 and secured a new $65.5 million superpriority debtor-in-possession term loan facility. This includes $25 million of new money term loans, with $16 million available immediately and $9 million as delayed draws, plus a $40.5 million roll-up of prepetition bridge loans.
The company expects all DIP obligations to convert into a senior secured first-lien exit term loan facility of up to $150 million upon emergence from Chapter 11. Nasdaq has moved to delist Inotiv’s common shares, with trading suspended on June 11, 2026. The company warns that existing equity holders are expected to be wiped out, as the restructuring plan contemplates cancelling all current equity without any recovery.
Inotiv, Inc. has entered a Restructuring Support Agreement with key creditors and begun prepackaged Chapter 11 cases to overhaul its balance sheet. The plan is expected to cut total funded debt by about $326 million, mainly by converting a large portion of existing loans and notes into new equity in a private, reorganized company.
Inotiv has secured debtor-in-possession financing that will roll into first-lien exit financing and intends to continue paying employees and vendors in the ordinary course as a debtor in possession. The company targets emergence from Chapter 11 within 50 days, but cautions that existing shareholders are expected to be wiped out, as all current equity interests will be cancelled with no recovery.
Inotiv, Inc. entered into a Second Supplemental Indenture for its 3.25% Convertible Senior Notes due 2027 to further extend the grace period for a missed interest payment. An interest payment of approximately $2.139 million was originally due on April 15, 2026.
The initial 30-day grace period to May 15, 2026 had already been extended to 44 days, through May 29, 2026, under a prior supplemental indenture. The new agreement extends the total grace period to 51 days, through and including June 5, 2026, giving the company additional time before an event of default could occur under these notes.
Inotiv, Inc. filed an initial ownership report for director John T. Young Jr. on Form 3. This filing establishes his status as a reporting insider but does not list any stock purchases, sales, option exercises, or other equity transactions. It is an administrative disclosure rather than a trading event.